Novel derivatives of quinolizidine alkaloid (−)-cytisine were synthesised. ADME properties, cytotoxicity against HEK293 cells and activity against viruses of influenza A/California/07/09(H1N1)pdm09 virus (IAV) and human parainfluenza virus type 3 (HPIV3) were evaluated. It was shown, that 9-carboxamides of methylcytisine (with phenyl and allyl urea’s fragments) are most active compounds against IAV probably due to predicted in silico peculiarity of their interactions with the 4R7B active site of IAV neuraminidase. Indexes of selectivity (SI) calculated as ratio of CC50/IC50 of these ureas are 47 and 59 correspondingly. It was also found, that derivatives obtained from allyl isocyanate and (−)-cytisine or 9,11-dibromocytisine are able to inhibit a reproduction of HPIV3 with SI = 58 and 95. Moreover, last compound - (1 R,5R)-N-allyl-9,11-dibromo-8-oxo-1,5,6,8-tetrahydro-2H-1,5-methanopyrido[1,2-a][1,5]diazocine-3(4H)-carboxamide with two bromine atom in 2-pyridone core of starting (−)-cytisine molecule, demonstrated high activity against HPIV3 (SI = 95) and moderate activity against IAV (SI = 16).
1 August 2025 in N.N. Priorov Journal of Traumatology and Orthopedics
BACKGROUND: Osteomyelitis remains a pressing problem due to its high recurrence rate and risk of serious complications. The situation is exacerbated by increasing antibiotic resistance, which reduces the effectiveness of conventional antibacterial therapy. In this context, the development of novel therapeutic strategies for osteomyelitis, especially in cases accompanied by critical bone loss, is of particular importance. AIM: The work aimed to test an approach to the treatment of purulent-septic inflammation complicated by bone tissue loss using biocomposite bone implants impregnated with a gel exhibiting multifunctional pharmacological activity, providing local antibacterial, anti-inflammatory, and osteogenic effects. The efficacy of the approach was evaluated in a rat model of experimental osteomyelitis. METHODS: The research methods included the development of polysaccharide gels with mechanical and rheological properties similar to those of soft tissues (G’ = 176–271 kPa, G’’ = 3.7–4.2 kPa), containing 250 mg/g of dry polymer of amikacin and vancomycin, 0.28 mg/mL of tenoxicam gel, and 12.83 ng/mL of a plasmid encoding bone morphogenetic protein (BMP), thereby ensuring the implants exert local antibacterial and targeted anti-inflammatory effects in combination with stimulation of bone tissue growth. Two types of nanoparticulate carriers of different diameters were introduced into the gel: hyaluronic gel nanoparticles with a bimodal size distribution (d = 100 and 3000 nm) for intracellular delivery of tenoxicam into phagocytic immunocompetent cells, and nanocapsules coated with a transfection agent (d = 50–100 nm) for transmembrane transport of the plasmid into non-phagocytic cells, whose ribosomes synthesize BMP-2, initiating differentiation via the osteogenic pathway. Antibiotics are released from the carrier only in response to bacterial attack on the implant via bacterial enzymes, ensuring a local concentration 200 times higher than the bactericidal threshold. Cytotoxicity, calculated per dry gel, was 1800 µg/mL. The minimum inhibitory concentration against Staphylococcus aureus 209P was 25 µg/mL, and the bactericidal concentration was 100 µg/mL. RESULTS: Biocomposites impregnated with a drug-containing gel were found to effectively inhibit local bacterial infection, reduce the overall level of local aseptic inflammation, and promote bone regeneration in osteomyelitis. CONCLUSION: The therapeutic approach to treating purulent-septic inflammation complicated by bone tissue loss using implants with multifunctional pharmacological activity should be regarded as promising.
28 March 2024 in HERALD of North-Western State Medical University named after I.I. Mechnikov
This review is devoted to the prospect of creating an artificial choledoch duct in case of its intraoperative injuries. Currently, there is no consensus on the optimal tactics of reconstructive surgical interventions, determining indications for the formation of biliodigestive anastomoses and transhepatic drainage of the biliary tract. The quality patients’ life after reconstruction in low mortality rate in this type of surgery decreases due to recurrent cholangitis, which in the future leads to liver abscesses and cirrhosis. The first attempts of prosthetics of the common bile duct were associated with the first use of stents in surgical practice. The second stage in the study of the reconstruction of the common bile duct were attempts to use stents and patches from transplants of subcutaneous veins, urethra, vagina of the rectus abdominis, and small intestine. The third stage in the development of this direction is using stents made with fibers of biodegradable polymer compounds. There several advantages of using biodegradable stents. Firstly, they are completely metabolized in the body and perform a skeleton function. Secondly, it is possible to use multilayer structures by means of cellular technologies that ensure the conformitythis of the model with the structures of the common bile duct. A stent from biodegradable material can be used with radiopaque dye and medications, for example, antibiotics to prevent cholangitis, or drugs supressing enhanced formation of fibrous tissue to prevent strictures.
With the resurgence of the coronavirus pandemic, the repositioning of FDA-approved drugs against coronovirus and finding alternative strategies for antiviral therapy are both important. We previously identified the viral lipid envelope as a potential target for the prevention and treatment of SARS-CoV-2 infection with plant alkaloids [1]. Here, we investigated the effects of eleven cyclic lipopeptides (CLPs), including well-known antifungal and antibacterial compounds, on the liposome fusion triggered by calcium, polyethylene glycol 8000, and a fragment of SARS-CoV-2 fusion peptide (816-827) by calcein release assays. Differential scanning microcalorimetry of the gel-to-liquid-crystalline and lamellar-to-inverted hexagonal phase transitions and confocal fluorescence microscopy demonstrated the relation of the fusion inhibitory effects of CLPs to alterations in lipid packing, membrane curvature stress and domain organization. The effects of the compounds were evaluated in an in vitro Vero -based cell model, and aculeacin A, anidulafugin, iturin A, and mycosubtilin attenuated the cytopathogenicity of SARS-CoV-2 without specific toxicity.
31 October 2026 in Complex Issues of Cardiovascular Diseases
Highlights Endothelium derived from induced pluripotent stem cells enhances osteoblast mineralization in the same way as primary endothelium, i.e. it is suitable as a functional model. The endothelium of a patient with a syndromic form of pathological calcification (Singleton–Merten syndrome) retains this ability, and the introduction of the mutant variant DDX58 into the endothelium weakens it. Macrophages, regardless of polarization, completely remove endothelium-dependent mineralization. The outcome of osteogenic differentiation is determined not by a single cell type, but by the complex composition of the cellular community. Aim. To determine how endothelial cells and macrophages influence osteogenic differentiation of cells targeted in pathological calcification, and whether this balance is altered by a DDX58 mutation causing Singleton–Merten syndrome (SMS), a monogenic form of vascular and valvular calcification. Methods. Endothelial cells were derived from induced pluripotent stem cells (iPSCs) of a patient with SMS and from a control line. Osteoblasts, smooth muscle cells and aortic valve interstitial cells were cultured in osteogenic medium alone and in direct co-culture with endothelium: iPSC-derived, primary (HUVEC), and primary transduced with wild-type or mutant DDX58. In part of the experiments, macrophages derived from the THP-1 line (unpolarised M0 or pro-inflammatory M1) were added to the co-culture. The endothelial phenotype of the derived cells was confirmed by immunocytochemistry for CD31 and von Willebrand factor. Mineralisation was assessed by alizarin red staining followed by dye extraction. Results. Endothelium was the strongest stimulator of mineralisation: in its presence osteoblasts mineralised the matrix about twelve-fold more intensely than in osteogenic medium alone. iPSC-derived endothelium acted identically to primary endothelium, including the patient-derived line. Introducing mutant DDX58 into primary endothelium weakened its stimulatory action, whereas the wild-type variant changed nothing; the DDX58 genotype of macrophages had no effect. Adding macrophages abolished the endothelial effect entirely – equally for M0 and M1 and in every combination with transduced endothelium – while macrophages alone did not induce osteogenic differentiation. In co-cultures with smooth muscle cells and valve interstitial cells endothelium also enhanced mineralisation, with no differences between DDX58 variants. Conclusion. Endothelium provides a permissive signal for osteogenic differentiation, macrophages block this signal, and the DDX58 mutation acts from the endothelial rather than the mesenchymal side. Therapies aimed at slowing pathological calcification should target intercellular communication rather than a single cell type.